Gentium S.p.a Earnings Preview: Can This Streak Continue?

Gentium S.p.a (NASDAQ:GENT) will report earnings before markets open on Tuesday, August 13th. Gentium Spa is a biopharmaceutical company focused on the discovery, research, development and manufacture of drugs for the treatment and prevention of a variety of vascular diseases and conditions related to cancer and cancer treatments.

Here is your Cheat Sheet to Gentium S.p.a Earnings:

Earnings Expectations: Analysts expect earnings of $0.04 per share on revenues of $12.08 million. Currently, the company’s P/E ratio stands at 70.05.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.2 to a profit $0.1. For the current year, the average estimate is a profit of $0.32, which is worse than the estimate ninety days ago.

Earnings Trends:

Here’s how Gentium S.p.a has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 11 14 33 30 36
Diluted EPS ($) -1.95 -0.41 0.38 0.23 0.06

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012 Mar. 31, 2013
Revenue ($) in millions 10.96 9.42 9.59 10.51
Diluted EPS ($) 0.06 0.02 0.05 0.06

Past Performance:
Gentium S.p.a has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]